The application of long-chained peptides (+30 aa) and relatively short proteins (<300 has experienced an increasing interest in recent years. However, a reliable production platform is still missing since manufacturing challenged by inherent problems such as mis-folding, aggregation, low yields. And neither chemical synthesis nor available recombinant approaches are effective efficient. ...